Name | DBPR112 |
---|
Description | DBPR112 (compound 78) is an orally active Furanopyrimidine-Based Epidermal Growth Factor Receptor inhibitor with IC50s of 15 nM and 48 nM for EGFRWT and EGFRL858R/T790M, respectively. DBPR112 has significant antitumor efficacy[1]. |
---|---|
Related Catalog | |
Target |
EGFRWT:15 nM (IC50) EGFRL858R/T790M:48 nM (IC50) |
References |
Molecular Formula | C32H31N5O3 |
---|---|
Molecular Weight | 533.62 |